Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-24

Clinical Trial Update: Long Term Effect of Buspirone on Esophageal Function and Esophageal Symptoms in Patients With Systematic Sclerosis (SSc) [EARLY_Phase 1]

View source ↗

Summary

Early Phase 1 trial evaluating the long-term effects of buspirone on esophageal function and esophageal symptoms in patients with systemic sclerosis; results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Buspirone (buspirone)

Snippet

Sponsor: Laikο General Hospital, Athens | Conditions: Systemic Sclerosis | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2016-10-24